Category IV indications for therapeutic apheresis - ASFA fourth special issue

Beth H. Shaz, Michael L. Linenberger, Nicholas Bandarenko, Jeffrey L. Winters, Haewon C. Kim, Marisa B. Marques, Ravindra Sarode, Joseph Schwartz, Robert Weinstein, Ashka Wirk, Zbigniew M. Szczepiorkowski

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations


The American Society for Apheresis (ASFA) Committee on Clinical Applications systematically and critically reviews published information on the use of therapeutic apheresis in clinical practice. On the basis of this review, selected diseases are assigned one of five categories (category I, II, III, IV, and P). The diseases, which were classified as category IV indications, and the rationale for such assignment are reviewed in this article. The diseases assigned to category I, II, III, and newly created category P are discussed in a separate article in this issue.

Original languageEnglish (US)
Pages (from-to)176-180
Number of pages5
JournalJournal of Clinical Apheresis
Issue number3
StatePublished - Jun 2007


  • Apheresis
  • Categories
  • Immunoadsorption
  • Leukocytapheresis
  • Photopheresis
  • Plasma exchange

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Category IV indications for therapeutic apheresis - ASFA fourth special issue'. Together they form a unique fingerprint.

Cite this